118 related articles for article (PubMed ID: 19365781)
21. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
22. The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.
Ravn P; Warming L; Christgau S; Christiansen C
Bone; 2004 Nov; 35(5):1216-21. PubMed ID: 15542048
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
[TBL] [Abstract][Full Text] [Related]
25. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
26. Effect of hormone therapy on the enteroinsular axis.
Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
[TBL] [Abstract][Full Text] [Related]
27. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
[TBL] [Abstract][Full Text] [Related]
28. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
29. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
[TBL] [Abstract][Full Text] [Related]
30. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
Rohr UD; Ehrly AM; Kuhl H
Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
[TBL] [Abstract][Full Text] [Related]
31. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
32. Enteric coating derived from marine sponge collagen.
Nicklas M; Schatton W; Heinemann S; Hanke T; Kreuter J
Drug Dev Ind Pharm; 2009 Nov; 35(11):1384-8. PubMed ID: 19832639
[TBL] [Abstract][Full Text] [Related]
33. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
Buch A; Shen L; Kelly S; Sahota R; Brezovic C; Bixler C; Powell J
Menopause; 1998; 5(2):107-12. PubMed ID: 9689205
[TBL] [Abstract][Full Text] [Related]
34. Transdermal delivery of contraceptives.
Friend DR
Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
36. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women].
Araya V; Contreras P; Aguirre C; Foradori A
Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735
[TBL] [Abstract][Full Text] [Related]
37. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
[TBL] [Abstract][Full Text] [Related]
38. Microparticles derived from marine sponge collagen (SCMPs): preparation, characterization and suitability for dermal delivery of all-trans retinol.
Swatschek D; Schatton W; Müller W; Kreuter J
Eur J Pharm Biopharm; 2002 Sep; 54(2):125-33. PubMed ID: 12191682
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous estradiol permeation, penetration and metabolism in pig and man.
Mahmoud A; Haberland A; Dürrfeld M; Heydeck D; Wagner S; Schafer-Korting M
Skin Pharmacol Physiol; 2005; 18(1):27-35. PubMed ID: 15608500
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
